[1] 陈盛新,栾智鹏. 药物治疗与病人保健［J］. 药学实践杂志,2009,27(1):73-77.
[2] 中华医学会心血管病学分会, 中华心血管病杂志编辑委员会. 慢性收缩性心力衰竭治疗建议［J］. 中华心血管病杂志,2002,30(1):7-23.
[3] 中华医学会心血管病学分会, 中华心血管病杂志编辑委员会, 中国循环杂志编辑委员会. 急性心肌梗死诊断和治疗指南［J］. 中华心血管病杂志,2001,29(12):710-725.
[4] Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report［J］. JAMA,2003,289(19):2560-2572.
[5] Cheng J, Zhang W, Zhang X,et al. Effect of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on all-cause mortality, cardiovascular deaths, and cardiovascular events in patients with diabetes mellitus: a meta-analysis［J］.JAMA Intern Med, 2014,174(5):773-85.
[6] Sandra SA, Elizabeth L, Lopez C. Intervention to improve adherence to ACC/AHA recommended adjunctive medications for the management of patients with an acute myocardial infarction［J］. Clin Cardiol, 2001,24:114-118.
[7] 中华医学会心血管病学分会, 中华心血管病杂志编辑委员会. 血管紧张素转化酶抑制剂在心血管病中应用中国专家共识［J］. 中华心血管杂志,2007,35(2):97-106.
[8] 翟晓波,朱 珺. 智能化和精确化用药监测软件的研发及应用［J］. 中国现代应用药学. 2010,27(4):361-366.
[9] 张晓荧,张四喜,周 微,等. 肾内科临床药师在药物整合服务中的实践探索［J］. 药学实践杂志,2015,33(1):88-90.